THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE

Details for Australian Patent Application No. 2002368153 (hide)

Owner CURAGEN CORPORATION

Inventors SPYTEK, Kimberly, A.; VERNET, Corine, A, M.; VOSS, Edward, Z.; ZHONG, Mei; ANDERSON, David, W.; BOLDOG, Ferenc, L.; CASMAN, Stacie, J.; EDINGER, Shlomit, R.; GANGOLLI, Esha, A.; GERLACH, Valerie, L.; GORMAN, linda; GUO, Xiaojia; KHRAMTSOV, Nikolai, V.; LI, Li; MACDOUGALL, John, R.; PENA, Carol, E., A.; PEYMAN, John, A.; PATTURAJAN, Meera; SHIMKETS, Richard, A.; SMITHSON, Glennda

Pub. Number AU-A-2002368153

PCT Number PCT/US2002/0244

PCT Pub. Number WO2004/015060

Priority 60/310,802 08.08.01 US; 60/310,795 08.08.01 US; 60/311,292 09.08.01 US; 60/311,751 10.08.01 US; 60/311,594 10.08.01 US; 60/311,571 10.08.01 US; 60/311,979 13.08.01 US; 60/312,892 16.08.01 US; 60/313,201 17.08.01 US; 60/314,031 21.08.01 US; 60/315,853 29.08.01 US; 60/322,716 17.09.01 US; 60/323,944 21.09.01 US; 60/359,294 21.02.02 US; 60/361,159 28.02.02 US; 60/360,890 28.02.02 US; 60/373,050 16.04.02 US; 60/372,998 16.04.02 US; 60/380,971 15.05.02 US; 60/380,970 15.05.02 US; 60/381,030 16.05.02 US; 10/211,689 01.08.02 US

Filing date 2 August 2002

Wipo publication date 25 February 2004

Event Publications

25 March 2004 Complete Application Filed

  Priority application(s): 60/310,802 08.08.01 US; 60/310,795 08.08.01 US; 60/311,292 09.08.01 US; 60/311,751 10.08.01 US; 60/311,594 10.08.01 US; 60/311,571 10.08.01 US; 60/311,979 13.08.01 US; 60/312,892 16.08.01 US; 60/313,201 17.08.01 US; 60/314,031 21.08.01 US; 60/315,853 29.08.01 US; 60/322,716 17.09.01 US; 60/323,944 21.09.01 US; 60/359,294 21.02.02 US; 60/361,159 28.02.02 US; 60/360,890 28.02.02 US; 60/373,050 16.04.02 US; 60/372,998 16.04.02 US; 60/380,971 15.05.02 US; 60/380,970 15.05.02 US; 60/381,030 16.05.02 US; 10/211,689 01.08.02 US

8 April 2004 Application Open to Public Inspection

  Published as AU-A-2002368153

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

5 August 2004 Section 223 Application Allowed

  CURAGEN CORPORATION The time in which to enter the national phase has been extended to 08 Apr 2004. Address for service in Australia - Wray & Associates Level 4, The Quadrant 1 William Street Perth WA 6831 2004

9 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002368154-IMPROVED SYNTHESIS FOR HYDROXYALKYLATED HETEROCYCLIC BASES

2002368152-3,6-DISUBSTITUTED AZABICYCLO (3.1.0)HEXANE DERIVATIVES USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS